VEON Ltd (NASDAQ:VEON) has been assigned an average recommendation of “Hold” from the nine analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $5.45.
Several analysts recently weighed in on VEON shares. Zacks Investment Research raised shares of VEON from a “hold” rating to a “buy” rating and set a $4.75 price objective on the stock in a research note on Thursday, October 5th. BidaskClub raised shares of VEON from a “sell” rating to a “hold” rating in a research note on Wednesday, January 3rd. Finally, ValuEngine raised shares of VEON from a “sell” rating to a “hold” rating in a research note on Monday, September 11th.
A hedge fund recently bought a new stake in VEON stock. Investec Asset Management North America Inc. bought a new position in VEON Ltd (NASDAQ:VEON) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,626,436 shares of the Wireless communications provider’s stock, valued at approximately $6,799,000. Investec Asset Management North America Inc. owned about 0.09% of VEON at the end of the most recent reporting period. Institutional investors and hedge funds own 15.05% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.com-unik.info/2018/01/09/veon-ltd-veon-receives-average-recommendation-of-hold-from-brokerages.html.
VEON Company Profile
What are top analysts saying about VEON? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for VEON and related companies.